Anxiolytic composition
US4783477A · kind A · utility
5Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 1987 |
| Grant date | Nov 8, 1988 |
| Priority date | — |
| Expiry date | Nov 9, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Medetomidine is useful in the treatment of anxiety disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.